Sinem Akçalı
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sinem Akçalı has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Şebnem Şenol Akar
Manisa Celal Bayar Univ, Dept Infect Dis & Clin Microbiol, Fac Med, Manisa, Turkey
5 shared publications - Erhan Eser
Manisa Celal Bayar University
4 shared publications - Ferya Karadağ Yalçın
Manisa Celal Bayar Univ, Hafsa Sultan Training & Res Hosp, Hlth Serv Directorate, Fac Med, Manisa, Turkiye
4 shared publications - Alkan Bal
Division of Pediatric Emergency Medicine, Department of Pediatrics, Manisa Celal Bayar University Faculty of Medicine, Manisa, Türkiye
3 shared publications - Hörü Gazi
Manisa Celal Bayar Univ, Tip Fak, Tibbi Mikrobiyol Anabilim Dali, Manisa, Turkiye
3 shared publications - Kübra Çiçek
Hatay Dörtyol İlçe Sağlık Müdürlüğü
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Bayt Publications in The Turkish Journal of Geriatrics
- Vol. 29 (2)
DETERMINING THE PREVALENCE OF RESPIRATORY SYNCYTIAL VIRUS AND RISK FACTORS ASSOCIATED WITH SEVERE ILLNESS IN PATIENTS AGED ≥60 YEARS PRESENTING WITH SYMPTOMS OF ACUTE RESPIRATORY TRACT INFECTION
Introduction: This study aimed to determine the prevalence of respiratory syncytial virus and risk factors associated with severe infection in adults aged ≥60 years who presented with symptoms of acute respiratory tract infection and to obtain regional epidemiological data. Materials and Method: The study was conducted on 230 patients aged ≥60 years who presented with symptoms of acute respiratory tract infection at the Manisa Celal Bayar University Emergency Department (n=130) and Pulmonology Outpatient Clinic (n=100) between January 1, 2024, and March 31, 2025. After obtaining informed consent from the patients, nasopharyngeal swab samples were collected and analyzed using the QIAstat-Dx Respiratory SARS-CoV-2 Panel. Demographic characteristics and potential risk factors were also recorded. Results: At least one pathogen was detected in 44.8% of the patients, with respiratory syncytial virus (6.5%), influenza (16.1%), and rhinovirus/enterovirus (11.3%) being the three most commonly identified pathogens. Among patients with respiratory syncytial virus infection, cardiovascular diseases (53.3%) were the most common comorbidity, although no significant association was found between viral positivity and chronic diseases. The hospitalization rate for lower respiratory tract infections was highest among patients with respiratory syncytial virus (69.2%), whereas it was 56.0% among patients with influenza. No hospitalization was required for patients positive for SARS-CoV-2. Additionally, patients with respiratory syncytial virus had a higher incidence of hypoxia (p=0.035) and a greater need for intensive care unit admission (p=0.023). Conclusion: Respiratory syncytial virus infections are associated with a more severe clinical course and an increased need for intensive care in older adults. Effective surveillance strategies for respiratory syncytial virus are required in Turkey. Keywords: Aged; Respiratory Syncytial Virus; Respiratory Tract Infections; Risk Factors.
- 1 January 2026
- Published by Bayt Publications in The Turkish Journal of Geriatrics
- Vol. 29 (2)
Open AccessDETERMINING THE PREVALENCE OF RESPIRATORY SYNCYTIAL VIRUS AND RISK FACTORS ASSOCIATED WITH SEVERE ILLNESS IN PATIENTS AGED ≥60 YEARS PRESENTING WITH SYMPTOMS OF ACUTE RESPIRATORY TRACT INFECTION
Introduction: This study aimed to determine the prevalence of respiratory syncytial virus and risk factors associated with severe infection in adults aged ≥60 years who presented with symptoms of acute respiratory tract infection and to obtain regional epidemiological data. Materials and Method: The study was conducted on 230 patients aged ≥60 years who presented with symptoms of acute respiratory tract infection at the Manisa Celal Bayar University Emergency Department (n=130) and Pulmonology Outpatient Clinic (n=100) between January 1, 2024, and March 31, 2025. After obtaining informed consent from the patients, nasopharyngeal swab samples were collected and analyzed using the QIAstat-Dx Respiratory SARS-CoV-2 Panel. Demographic characteristics and potential risk factors were also recorded. Results: At least one pathogen was detected in 44.8% of the patients, with respiratory syncytial virus (6.5%), influenza (16.1%), and rhinovirus/enterovirus (11.3%) being the three most commonly identified pathogens. Among patients with respiratory syncytial virus infection, cardiovascular diseases (53.3%) were the most common comorbidity, although no significant association was found between viral positivity and chronic diseases. The hospitalization rate for lower respiratory tract infections was highest among patients with respiratory syncytial virus (69.2%), whereas it was 56.0% among patients with influenza. No hospitalization was required for patients positive for SARS-CoV-2. Additionally, patients with respiratory syncytial virus had a higher incidence of hypoxia (p=0.035) and a greater need for intensive care unit admission (p=0.023). Conclusion: Respiratory syncytial virus infections are associated with a more severe clinical course and an increased need for intensive care in older adults. Effective surveillance strategies for respiratory syncytial virus are required in Turkey. Keywords: Aged; Respiratory Syncytial Virus; Respiratory Tract Infections; Risk Factors.
- Open Access
- 24 October 2023
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 1 (4) , 79-85
The role of clinical pulmonary infection score and some infection biomarkers in diagnosis and follow up in hospital acquired pneumonia
Aims: Early diagnosis and treatment affect mortality in hospital-acquired pneumonia (HAP). Therefore, clinicians need some objective parameters for guiding treatment. The aim of this study was to determine the course of ‘‘clinical pulmonary infection score’’ (CPIS), C-reactive protein (CRP) and procalcitonin (PCT) in patients under treatment as well as the relationship of these parameters with each other and mortality. Methods: This single-center, prospective, cross-sectional study focused on cases of HAP in hospitalized patients. In patients with HAP; CPIS, CRP and PCT assays were assessed on the first day. Appropriate treatment was initiated according to Turkish Thoracic Society HAP Task Force recommendations. On the 3rd day, CPIS evaluation and on the 4th day CRP and PCT analysis were repeated. All the patients’ one month mortality rates were recorded. Results: Among the 25 patients, there were 14 females. The mean age was 66±15 years. The mean duration for HAP development was 9.4±8.2 days. With a cutt-off value of 65 for age CPIS, CRP, PCT, length of hospital stay and mortality rate was not found different (p>0.05), however as the age increased HAP development duration significantly decreased (r=-0.416, p=0.03). We demonstrated a significant change between the first and the follow-up values of fever (p=0.046), leukocyte (p<0.001), PaO2/FiO2 (p=0.016), secretion presence (p<0.001), culture positivity (p<0.001) as well as total CPIS (p=0.030). However, there wasn’t a significant difference in CRP and PCT levels. We couldn’t show any relation between CPIS domains, total CPIS, CRP, PCT, HAP development duration and mortality rates. Conclusion: Monitoring HAP treatment according to CPIS was found better than CRP and PCT. However, these parameters had no effect on mortality. For more accurate comments, studies with more patients are needed.
- 24 October 2023
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 1 (4) , 79-85
Open AccessThe role of clinical pulmonary infection score and some infection biomarkers in diagnosis and follow up in hospital acquired pneumonia
Aims: Early diagnosis and treatment affect mortality in hospital-acquired pneumonia (HAP). Therefore, clinicians need some objective parameters for guiding treatment. The aim of this study was to determine the course of ‘‘clinical pulmonary infection score’’ (CPIS), C-reactive protein (CRP) and procalcitonin (PCT) in patients under treatment as well as the relationship of these parameters with each other and mortality. Methods: This single-center, prospective, cross-sectional study focused on cases of HAP in hospitalized patients. In patients with HAP; CPIS, CRP and PCT assays were assessed on the first day. Appropriate treatment was initiated according to Turkish Thoracic Society HAP Task Force recommendations. On the 3rd day, CPIS evaluation and on the 4th day CRP and PCT analysis were repeated. All the patients’ one month mortality rates were recorded. Results: Among the 25 patients, there were 14 females. The mean age was 66±15 years. The mean duration for HAP development was 9.4±8.2 days. With a cutt-off value of 65 for age CPIS, CRP, PCT, length of hospital stay and mortality rate was not found different (p>0.05), however as the age increased HAP development duration significantly decreased (r=-0.416, p=0.03). We demonstrated a significant change between the first and the follow-up values of fever (p=0.046), leukocyte (p<0.001), PaO2/FiO2 (p=0.016), secretion presence (p<0.001), culture positivity (p<0.001) as well as total CPIS (p=0.030). However, there wasn’t a significant difference in CRP and PCT levels. We couldn’t show any relation between CPIS domains, total CPIS, CRP, PCT, HAP development duration and mortality rates. Conclusion: Monitoring HAP treatment according to CPIS was found better than CRP and PCT. However, these parameters had no effect on mortality. For more accurate comments, studies with more patients are needed.
- 23 October 2023
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 57 (4) , 580-596
Seasonal Trends and Interactions of Viral Pathogens in Children Presenting with Acute Respiratory Tract Infections in the Advancing Periods of SARS-Cov-2 Pandemic
Although various bacteria and viruses have been identified in the etiology of acute respiratory tract infections (ARI), 90% of acute ARIs that develop in children are of viral origin. The aim of this study was to investigate the seasonal trends and interactions between infectious agents and to determine the risk factors associated with ARI in children aged 1-15 years admitted to the Pediatric Emergency Department of Manisa Celal Bayar University Hospital in the advancing periods of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic. To determine the bacterial and viral agents, samples were taken from 314 patients attending to the hospital with symptoms suggestive for ARI, between 06/01/2021 and 05/31/2022. Viral and bacterial agents were identified by multiplex polymerase chain reaction (PCR) and automated identification system, respectively. Demographic data of the participants and possible risk fac- tors for ARI were recorded in the questionnaires. In the study, viral agents were detected in 77.3% of the children, and the most common infectious agent was rhinovirus/enterovirus (RV/EV) (36.3%), followed by influenza viruses (11.2%), and SARS-CoV-2 (10.5%). While RV/EV positivity was found to be higher in children with moderate and below average (p< 0.001) hand hygiene, influenza positivity was found higher in those attending school/preschool institution (p< 0.001) and whose mothers working full-time (p< 0.001). Respiratory syncytial virus positivity was associated with maternal smoking (p= 0.013) and home overcrowding (p= 0.014). Bacterial colonization was detected in 33 (11.6%) of 284 children whose swabs were taken for both bacterial and viral agents and the most frequently detected agents were Staphylococcus aureus (60.6%) and Pseudomonas aeruginosa (15.2%). Having siblings (p= 0.008) and maternal smoking (p= 0.012) were found to be associated with the detection of bacterial agents. In this study, in the advanced period of the pandemic, the most detected agents and seasonal characteristics were found to be similar to the pre-pandemic period. It is thought that knowing the regional etiology and risk factors will contribute to taking the necessary local control and protective measures.
- 23 October 2023
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 57 (4) , 580-596
Seasonal Trends and Interactions of Viral Pathogens in Children Presenting with Acute Respiratory Tract Infections in the Advancing Periods of SARS-Cov-2 Pandemic
Although various bacteria and viruses have been identified in the etiology of acute respiratory tract infections (ARI), 90% of acute ARIs that develop in children are of viral origin. The aim of this study was to investigate the seasonal trends and interactions between infectious agents and to determine the risk factors associated with ARI in children aged 1-15 years admitted to the Pediatric Emergency Department of Manisa Celal Bayar University Hospital in the advancing periods of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic. To determine the bacterial and viral agents, samples were taken from 314 patients attending to the hospital with symptoms suggestive for ARI, between 06/01/2021 and 05/31/2022. Viral and bacterial agents were identified by multiplex polymerase chain reaction (PCR) and automated identification system, respectively. Demographic data of the participants and possible risk fac- tors for ARI were recorded in the questionnaires. In the study, viral agents were detected in 77.3% of the children, and the most common infectious agent was rhinovirus/enterovirus (RV/EV) (36.3%), followed by influenza viruses (11.2%), and SARS-CoV-2 (10.5%). While RV/EV positivity was found to be higher in children with moderate and below average (p< 0.001) hand hygiene, influenza positivity was found higher in those attending school/preschool institution (p< 0.001) and whose mothers working full-time (p< 0.001). Respiratory syncytial virus positivity was associated with maternal smoking (p= 0.013) and home overcrowding (p= 0.014). Bacterial colonization was detected in 33 (11.6%) of 284 children whose swabs were taken for both bacterial and viral agents and the most frequently detected agents were Staphylococcus aureus (60.6%) and Pseudomonas aeruginosa (15.2%). Having siblings (p= 0.008) and maternal smoking (p= 0.012) were found to be associated with the detection of bacterial agents. In this study, in the advanced period of the pandemic, the most detected agents and seasonal characteristics were found to be similar to the pre-pandemic period. It is thought that knowing the regional etiology and risk factors will contribute to taking the necessary local control and protective measures.
- 15 April 2023
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 57 (2) , 238-251
Efficacy of Homologous and Heterologous Vaccine Applications on SARS-CoV-2 Omicron Variant: Cohort of Manisa Celal Bayar University Healthcare Workers
This study was aimed to determine the efficacy of homologous (only CoronaVac or only Pfizer-BioN- Tech) and heterologous (CoronaVac and Pfizer-BioNTech) vaccines during the period when the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron variant was dominant in T0rkiye. Coro- navirus disease-2019 (COVID-2019) infection was confirmed by reverse transcriptase polymerase chain reaction and data on vaccination status against COVID-19 were evaluated during the period of 15 January 2022-1 May 2022 when the SARS-CoV-2 Omicron variant was dominant among 1854 employees fol- lowed in the SARS-CoV-2 Vaccine Cohort of Manisa Celal Bayar University (MCBU) Hospital Health Work-ers. Two separate reference groups were used in the evaluation of vaccine efficacy: those who were never vaccinated and those who received only two doses of CoronaVac. The efficacy of homologous and heter- ologous vaccine models was evaluated with relative risks and attributable risk percentages. MS Excel, SPSS 23.0 and STATA 14.1 package programs were used for statistical analysis. The mean age of the participants was 36.6 +/- 10.0. During the period from January 15th to May 1st 2022, 372 hospital workers were infected with COVID-19. Taking the never vaccinated as the reference group, the most effective model was found to be only the three or more doses of the Pfizer-BioNTech primary vaccination model (85.8%, 95% CI= 40.7-96.6). Models consisting of a single dose of CoronaVac (6.5%, 95% CI=-56.3-44.2) or a single dose of Pfizer-BioNTech (17.7%, 95% CI=-30.2-48.0) booster dose administered after two doses of primary CoronaVac vaccination was not found to be effective against the SARS-CoV-2 Omicron variant. When only two doses of primary CoronaVac vaccination model was taken as the reference group, the model consist-ing of two doses CoronaVac followed by two Pfizer-BioNTech booster doses was effective as 38.4% (95% CI= 15.4-55.3), whereas three doses of Pfizer-BioNTech booster model was effective as 56.4% (95% CI= 33.9-71.3). To conclude, none of the models other than the homologous or heterologous vaccine models containing at least three doses of Pfizer-BioNTech vaccine were effective compared to those unvaccinated. Compared with those who received only two doses of primary Coronavac, models with at least three dos-es of Pfizer-BioNTech reminder doses were more effective against the Omicron variant than other models.
- 15 April 2023
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 57 (2) , 238-251
Efficacy of Homologous and Heterologous Vaccine Applications on SARS-CoV-2 Omicron Variant: Cohort of Manisa Celal Bayar University Healthcare Workers
This study was aimed to determine the efficacy of homologous (only CoronaVac or only Pfizer-BioN- Tech) and heterologous (CoronaVac and Pfizer-BioNTech) vaccines during the period when the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron variant was dominant in T0rkiye. Coro- navirus disease-2019 (COVID-2019) infection was confirmed by reverse transcriptase polymerase chain reaction and data on vaccination status against COVID-19 were evaluated during the period of 15 January 2022-1 May 2022 when the SARS-CoV-2 Omicron variant was dominant among 1854 employees fol- lowed in the SARS-CoV-2 Vaccine Cohort of Manisa Celal Bayar University (MCBU) Hospital Health Work-ers. Two separate reference groups were used in the evaluation of vaccine efficacy: those who were never vaccinated and those who received only two doses of CoronaVac. The efficacy of homologous and heter- ologous vaccine models was evaluated with relative risks and attributable risk percentages. MS Excel, SPSS 23.0 and STATA 14.1 package programs were used for statistical analysis. The mean age of the participants was 36.6 +/- 10.0. During the period from January 15th to May 1st 2022, 372 hospital workers were infected with COVID-19. Taking the never vaccinated as the reference group, the most effective model was found to be only the three or more doses of the Pfizer-BioNTech primary vaccination model (85.8%, 95% CI= 40.7-96.6). Models consisting of a single dose of CoronaVac (6.5%, 95% CI=-56.3-44.2) or a single dose of Pfizer-BioNTech (17.7%, 95% CI=-30.2-48.0) booster dose administered after two doses of primary CoronaVac vaccination was not found to be effective against the SARS-CoV-2 Omicron variant. When only two doses of primary CoronaVac vaccination model was taken as the reference group, the model consist-ing of two doses CoronaVac followed by two Pfizer-BioNTech booster doses was effective as 38.4% (95% CI= 15.4-55.3), whereas three doses of Pfizer-BioNTech booster model was effective as 56.4% (95% CI= 33.9-71.3). To conclude, none of the models other than the homologous or heterologous vaccine models containing at least three doses of Pfizer-BioNTech vaccine were effective compared to those unvaccinated. Compared with those who received only two doses of primary Coronavac, models with at least three dos-es of Pfizer-BioNTech reminder doses were more effective against the Omicron variant than other models.
- 4 October 2022
- Published by Georg Thieme Verlag KG in Journal of Pediatric Infectious Diseases
- Vol. 17 (06) , 308-316
Serum Vitamin D Levels in Relation to Development of Multisystem Inflammatory Syndrome in Pediatric COVID-19
Objective The aim of the study is to evaluate vitamin D (vit D) levels in children with and without development of multisystem inflammatory syndrome in children (MIS-C) after coronavirus disease 2019 (COVID-19) and also between those with severe and moderate MIS-C. Methods This comprises retrospective data of 68 patients including 34 patients with MIS-C and admitted into the pediatric intensive care unit (MIS-C group) and 34 patients without MIS-C (non-MIS-C group) were analyzed for their presenting characteristics, serum vit D levels, ventilatory needs, and prognostic scores. Results Vit D levels were significantly lower in patients with versus without MIS-C [9 (2–18) vs. 19 (10–43) ng/mL, p <0.001], and also in patients with severe versus moderate MIS-C [7.5 (2–17) vs. 9 (5–18) ng/mL, p = 0.024]. Vit D deficiency (levels <12 ng/mL) was more common in the MIS-C versus non-MIS-C group (79.4 vs. 11.8%, p <0.001) and in severe versus moderate MIS-C (92.9 vs. 70.0%, p <0.001). The severe versus moderate MIS-C was associated with significantly higher levels of procalcitonin [7.6 (0.9–82) vs. 1.7 (0.2–42) ng/mL, p = 0.030] and troponin [211 (4.8–4,545) vs. 14.2 (2.4–3,065) ng/L, p = 0.008] and higher likelihood of reduced ejection fraction (75.0 vs. 15.4%, p = 0.004). Conclusion Our findings indicate the higher prevalence of vit D deficiency in pediatric COVID-19 patients with versus without MIS-C, as well as in those with severe versus moderate MIS-C. Higher troponin and procalcitonin levels and dyspnea at presentation seem also to be risk factors for severe MIS-C, more pronounced cardiac dysfunction, and poorer prognosis.
- 4 October 2022
- Published by Georg Thieme Verlag KG in Journal of Pediatric Infectious Diseases
- Vol. 17 (06) , 308-316
Serum Vitamin D Levels in Relation to Development of Multisystem Inflammatory Syndrome in Pediatric COVID-19
Objective The aim of the study is to evaluate vitamin D (vit D) levels in children with and without development of multisystem inflammatory syndrome in children (MIS-C) after coronavirus disease 2019 (COVID-19) and also between those with severe and moderate MIS-C. Methods This comprises retrospective data of 68 patients including 34 patients with MIS-C and admitted into the pediatric intensive care unit (MIS-C group) and 34 patients without MIS-C (non-MIS-C group) were analyzed for their presenting characteristics, serum vit D levels, ventilatory needs, and prognostic scores. Results Vit D levels were significantly lower in patients with versus without MIS-C [9 (2–18) vs. 19 (10–43) ng/mL, p <0.001], and also in patients with severe versus moderate MIS-C [7.5 (2–17) vs. 9 (5–18) ng/mL, p = 0.024]. Vit D deficiency (levels <12 ng/mL) was more common in the MIS-C versus non-MIS-C group (79.4 vs. 11.8%, p <0.001) and in severe versus moderate MIS-C (92.9 vs. 70.0%, p <0.001). The severe versus moderate MIS-C was associated with significantly higher levels of procalcitonin [7.6 (0.9–82) vs. 1.7 (0.2–42) ng/mL, p = 0.030] and troponin [211 (4.8–4,545) vs. 14.2 (2.4–3,065) ng/L, p = 0.008] and higher likelihood of reduced ejection fraction (75.0 vs. 15.4%, p = 0.004). Conclusion Our findings indicate the higher prevalence of vit D deficiency in pediatric COVID-19 patients with versus without MIS-C, as well as in those with severe versus moderate MIS-C. Higher troponin and procalcitonin levels and dyspnea at presentation seem also to be risk factors for severe MIS-C, more pronounced cardiac dysfunction, and poorer prognosis.
- 30 August 2022
- Published by Journal of Biotechnology and Strategic Health Research in JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH
- Vol. 6 (2) , 86-93
Maymun Çiçeği Virüsünün Yapısal Özellikleri ve Laboratuvar Tanısı
Maymun Çiçek Virüsü daha önce endemik olarak Afrika'da görülen ve çiçek hastalığı benzeri hastalığa neden olan bir zoonozdur. Son zamanlarda insandan insana bulaşların artışı ve Afrika'nın ötesindeki salgınların ortaya çıkması ile dikkatleri üzerine çekmiştir. Hastalık genellikle kendini sınırlamakta ancak %10‘a varan mortalite ve ciddi komplikasyonlar görülebilmektedir. Hastalığın spesifik bir klinik tablosu yoktur ve Maymun Çiçeği Virüsü diğer bazı virüs türleri ile yapısal benzerlik sergilemektedir. Henüz spesifik bir aşısı ve tedavisi olmayan bu etkenin hızlı ve erken tanınması salgın yönetimindeki en etkili basamak olacaktır. Bu derlemede Maymun çiçeği virüsünün yapısı ve laboratuvar tanısında kullanılan yöntemler gözden geçirilmiştir.
- 30 August 2022
- Published by Journal of Biotechnology and Strategic Health Research in JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH
- Vol. 6 (2) , 86-93
Maymun Çiçeği Virüsünün Yapısal Özellikleri ve Laboratuvar Tanısı
Maymun Çiçek Virüsü daha önce endemik olarak Afrika'da görülen ve çiçek hastalığı benzeri hastalığa neden olan bir zoonozdur. Son zamanlarda insandan insana bulaşların artışı ve Afrika'nın ötesindeki salgınların ortaya çıkması ile dikkatleri üzerine çekmiştir. Hastalık genellikle kendini sınırlamakta ancak %10‘a varan mortalite ve ciddi komplikasyonlar görülebilmektedir. Hastalığın spesifik bir klinik tablosu yoktur ve Maymun Çiçeği Virüsü diğer bazı virüs türleri ile yapısal benzerlik sergilemektedir. Henüz spesifik bir aşısı ve tedavisi olmayan bu etkenin hızlı ve erken tanınması salgın yönetimindeki en etkili basamak olacaktır. Bu derlemede Maymun çiçeği virüsünün yapısı ve laboratuvar tanısında kullanılan yöntemler gözden geçirilmiştir.
- Open Access
- 5 August 2022
- Published by Galenos Yayinevi in Journal of Dr Behcet Uz Children s Hospital
- Vol. 12 (2) , 151-158
Respiratory Viruses in Pediatric Patients with Suspected COVID-19 at the Early Stages of the Pandemic: A Single-center Experience
- 5 August 2022
- Published by Galenos Yayinevi in Journal of Dr Behcet Uz Children s Hospital
- Vol. 12 (2) , 151-158
Open AccessRespiratory Viruses in Pediatric Patients with Suspected COVID-19 at the Early Stages of the Pandemic: A Single-center Experience
- 6 June 2022
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 28 (9) , 1310-1316
Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: A prospective study
- 6 June 2022
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 28 (9) , 1310-1316
Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: A prospective study
- 25 April 2022
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 56 (2) , 274-287
Sağlık Çalışanları SARS-CoV-2 Hasta Kohordunda Antikor Sürdürülebilirliği
In this study, it was aimed to evaluate one-year follow-up of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) specific antibodies formed against the virus binding site, in a coronavirus disease-2019 (COVID-19) positive case cohort (n= 413) between the period March 2020 to December 2020 in Manisa Celal Bayar University Hospital, until July 2021. SARS-CoV-2 antibodies were determined by the chemiluminescent enzyme immunoassay (CLIA) method. Values of 1.0 and above were considered positive. Chi-square tests and Joinpoint regression analysis (version 4.7.0) were used in the statistical analyses. The mean age of the participants was 34.9 +/- 9.3 and 60.2% of them were women. Between 21-30 days after the diagnosis of COVID-19, total antibody level was above the threshold value in 72.2% (n= 126) of the participants, while this rate increased to 79.1% (n= 240) in 31-60 day interval. In the following period, this rate decreased to 38.8% (n= 108) in days 211st to 240th. Antibody response could not be detected in 76 (20.7%) of 367 employees who have initially been followed up. The percentage of total antibody positivity prevalence ranged from 98.9% to 96.1% in the 31-210th day after diagnosis, in the follow-up of 291 employees whose total antibody positivity was detected after diagnosis. According to the results of the Joinpoint regression analysis, after the diagnosis of COVID-19, the curve showing the percentage of antibody positivity was broken at two points: The first breaking point was observed in 181-210th days (6-7 months) (p= 0.069), and the second breaking point was in 271-300th days (9-10 months) (p< 0.001). As a result, the highest antibody positivity rates were detected after the 30th day of the disease onset and antibody positivity was maintained in the first seven months after diagnosis; the antibody positivity rate decreased to 25% at the end of the first year.
- 25 April 2022
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 56 (2) , 274-287
Sağlık Çalışanları SARS-CoV-2 Hasta Kohordunda Antikor Sürdürülebilirliği
In this study, it was aimed to evaluate one-year follow-up of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) specific antibodies formed against the virus binding site, in a coronavirus disease-2019 (COVID-19) positive case cohort (n= 413) between the period March 2020 to December 2020 in Manisa Celal Bayar University Hospital, until July 2021. SARS-CoV-2 antibodies were determined by the chemiluminescent enzyme immunoassay (CLIA) method. Values of 1.0 and above were considered positive. Chi-square tests and Joinpoint regression analysis (version 4.7.0) were used in the statistical analyses. The mean age of the participants was 34.9 +/- 9.3 and 60.2% of them were women. Between 21-30 days after the diagnosis of COVID-19, total antibody level was above the threshold value in 72.2% (n= 126) of the participants, while this rate increased to 79.1% (n= 240) in 31-60 day interval. In the following period, this rate decreased to 38.8% (n= 108) in days 211st to 240th. Antibody response could not be detected in 76 (20.7%) of 367 employees who have initially been followed up. The percentage of total antibody positivity prevalence ranged from 98.9% to 96.1% in the 31-210th day after diagnosis, in the follow-up of 291 employees whose total antibody positivity was detected after diagnosis. According to the results of the Joinpoint regression analysis, after the diagnosis of COVID-19, the curve showing the percentage of antibody positivity was broken at two points: The first breaking point was observed in 181-210th days (6-7 months) (p= 0.069), and the second breaking point was in 271-300th days (9-10 months) (p< 0.001). As a result, the highest antibody positivity rates were detected after the 30th day of the disease onset and antibody positivity was maintained in the first seven months after diagnosis; the antibody positivity rate decreased to 25% at the end of the first year.
- Open Access
- 1 April 2022
- Published by Turkish Journal of Public Health in Türkiye Halk Sağlığı Dergisi
- Vol. 20 (1) , 117-128
Türkiye’de bir üçüncü basamak hastanede sağlık çalışanlarında SARS-CoV-2 seroprevalansı
Objective: The aim of this study is to investigate the previous four months (March-July 2020) SARS-CoV-2 infection rate, seroprevalence and the variables affecting these in HCWs in a university hospital. Methods: The present study is a SARS-CoV-2 seroprevalence study on HCWs working in a tertiary hospital during the first stage (March-July 2020) of the outbreak in Turkey. The presence of IgM and IgG antibodies against the spike structure of the virus was investigated by the chemiluminescent enzyme immunoassay (CLIA) method using the commercial antibody kit (COV2T, Siemens®, Tarrytown, NY, US). Participants’ socio-demographic characteristics, health status, lifestyle, risky occupational and social and personal protective equipment (PPE) usage were independent variables of the study. Chi-square test and Fisher’s exact test were used in univariate analyzes, and accepted type 1 error value was 0.05. The analyzes were made using the SPSS 23.0 package program. Results: 1177 out of a total of 1702 health workers participated in the study. Participation rate was 69.1% . The mean age of the study group was 35.3 ± 9.8 and 62.7% were females. SARS-CoV-2 infection rate detected by nucleic acid amplification test (NAAT-PCR) or antibody test (Elisa) was (18/1177) 1.5%; The seroprevalence of SARS-CoV-2 was 1.01%. 17% of the entire SARS-CoV-2 cases were asymptomatic. The highest infection prevalence was significantly higher in auxiliary health workers (3.7%) compared to other groups. The presence of symptoms HCW’s and their family members that did not exist before in the last 15 days, being overweight or obese and consulting as contacted person in survelliance unit were significantly related to having SARS-CoV-2 infection (p
- 1 April 2022
- Published by Turkish Journal of Public Health in Türkiye Halk Sağlığı Dergisi
- Vol. 20 (1) , 117-128
Open AccessTürkiye’de bir üçüncü basamak hastanede sağlık çalışanlarında SARS-CoV-2 seroprevalansı
Objective: The aim of this study is to investigate the previous four months (March-July 2020) SARS-CoV-2 infection rate, seroprevalence and the variables affecting these in HCWs in a university hospital. Methods: The present study is a SARS-CoV-2 seroprevalence study on HCWs working in a tertiary hospital during the first stage (March-July 2020) of the outbreak in Turkey. The presence of IgM and IgG antibodies against the spike structure of the virus was investigated by the chemiluminescent enzyme immunoassay (CLIA) method using the commercial antibody kit (COV2T, Siemens®, Tarrytown, NY, US). Participants’ socio-demographic characteristics, health status, lifestyle, risky occupational and social and personal protective equipment (PPE) usage were independent variables of the study. Chi-square test and Fisher’s exact test were used in univariate analyzes, and accepted type 1 error value was 0.05. The analyzes were made using the SPSS 23.0 package program. Results: 1177 out of a total of 1702 health workers participated in the study. Participation rate was 69.1% . The mean age of the study group was 35.3 ± 9.8 and 62.7% were females. SARS-CoV-2 infection rate detected by nucleic acid amplification test (NAAT-PCR) or antibody test (Elisa) was (18/1177) 1.5%; The seroprevalence of SARS-CoV-2 was 1.01%. 17% of the entire SARS-CoV-2 cases were asymptomatic. The highest infection prevalence was significantly higher in auxiliary health workers (3.7%) compared to other groups. The presence of symptoms HCW’s and their family members that did not exist before in the last 15 days, being overweight or obese and consulting as contacted person in survelliance unit were significantly related to having SARS-CoV-2 infection (p